Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Procarbazine MeSH Descriptor Data 2026


MeSH Heading
Procarbazine
Tree Number(s)
D02.065.277.727
D02.241.223.100.100.655
D02.455.426.559.389.127.085.655
Unique ID
D011344
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D011344
Scope Note
An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
Entry Term(s)
Matulane
Natulan
Procarbazine Hydrochloride
Procarbazine Monohydrobromide
Procarbazine Monohydrochloride
Pharm Action
Antineoplastic Agents
Registry Numbers
35S93Y190K
0
18969-59-0
XH0NPH5ZX8
Related Numbers
13309-74-5
18969-59-0
366-70-1
671-16-9
XH0NPH5ZX8
CAS Type 1 Name
Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)-
Previous Indexing
Antineoplastic Agents (1966-1970)
Benzoates (1966-1970)
Public MeSH Note
74
History Note
74(71)
Date Introduced
1974/01/01
Last Updated
2016/07/01
Procarbazine Preferred
Natulan Narrower
Procarbazine Monohydrobromide Narrower
Procarbazine Hydrochloride Narrower
Matulane Narrower
page delivered in 0.141s